Circulating mitochondrial cell-free DNA levels are associated with the recurrence of atrial fibrillation after catheter ablation for atrial fibrillation
Year: 2025
Type: article
Study design: Observational Study
Abstract: Background: Although catheter ablation, including pulmonary vein isolation, is the primary nonpharmacological therapy for atrial fibrillation (AF), atrial arrhythmia often recurs. Recent studies have linked circulating mitochondrial cell-free DNA (mt-cfDNA), a potential contributor to inflammatory disorders, with AF. In this study, we evaluated the relationship between plasma mt-cfDNA levels and AF recurrence after catheter ablation in patients with AF. Methods: Peripheral blood was obtained from 58 patients with AF (34 paroxysmal and 24 persistent AF) who underwent catheter ablation and from the control group (10 patients without AF). We extracted total cfDNA and mt-cfDNA from the patients. Results: The total cfDNA concentration and copy number of mt-cfDNA were significantly higher in patients with AF than in controls. During the 16-month follow-up after catheter ablation, AF recurred in 11 patients (19.0 %). In patients with AF, the copy number of mt-cfDNA before catheter ablation was higher in the recurrent group than in the non-recurrent group. However, total cfDNA concentrations did not differ significantly between patients with and without AF recurrence. The left atrial volume index (LAVI) was higher in patients with recurrent AF than in those without. Cox proportional hazards regression analysis showed that the mt-cfDNA copy number was significantly associated with AF recurrence after catheter ablation, independent of age, sex, body mass index, LAVI, and AF type. Conclusion: Elevated mt-cfDNA levels may be a sensitive predictor of AF recurrence after catheter ablation in patients with AF.
Authors: Tomoko Takahashi(Data curation, Investigation, Writing – original draft), Takeshi Soeki(Conceptualization, Funding acquisition, Investigation, Supervision, Writing – original draft), Kazuki Tezuka(Investigation, Writing – original draft), Tomomi Matsuura(Investigation, Methodology), Etsuko Uematsu(Investigation, Methodology), Hiroyuki Aibara(Investigation), Ryou Bando(Data curation), Robert Zheng(Investigation), Tomonori Takahashi(Data curation), Yoshihito Saijo(Data curation), Yutaka Kawabata(Formal analysis), Muneyuki Kadota(Formal analysis), Tomoya Hara(Formal analysis), Rie Ueno(Data curation), Takayuki Ise(Investigation), Koji Yamaguchi(Investigation, Methodology), Shusuke Yagi(Writing – review & editing), Hirotsugu Yamada(Writing – review & editing), Daiju Fukuda(Methodology, Writing – review & editing), Masataka Sata(Funding acquisition, Resources, Supervision, Writing – review & editing)
Institutions: Tokushima University, Osaka Metropolitan University
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,810
Awards: Mechanism of cardiac-specific inflammation mediated by PAR-2 signaling and development of new cardiac disease therapies, Elucidation of chronic inflammation induced by life-style related dseaseas and development of diagnosis and novel therpies for atherosclerotic diseases, Elucidation of the mechanism of cardiac remodeling and arrhythmogenesis via toll-like receptor (TLR) 9
OpenAlex ID: W4415218924
